Korea Arlico Pharm (260660) Stock Overview

Korea Arlico Pharm Co.,Ltd. engages in the research and development, production, and sale of medicines in South Korea. The company provides ETC, OTC, health functional, and other products; and active ingredients. It offers products in the areas of circulatory system, anti-platelet, dementia, muscle relaxants, diabetes, nsaids and analgesics, antibiotic and chemotherapy, allergy and respiratory disease, ointment/cream, health functional food, vitamin and health supplements, anti-inflammatory analgesic, digestive system, and metabolic disease. The company is based in Seoul, South Korea.